2020 Annual Meeting | C258 - Vascular Cognitive Impairment and Dementia: Current Status and Future

��ɫ��

2020 Annual Meeting | C258 - Vascular Cognitive Impairment and Dementia: Current Status and Future

Date Friday 05/01/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mark R. Etherton, MD

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should be able to discuss the diagnostic challenges and current and potential future therapeutic approaches for the management of vascular cognitive impairment and dementia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:25 AM	Speaker	Vascular Cognitive Impairment/Dementia: Understanding the Clinical Impact Mark R. Etherton, MD
07:25 AM - 07:30 AM	Q&A	Questions and Answers Mark R. Etherton, MD
07:30 AM - 08:05 AM	Speaker	James F. Meschia, MD, FAAN
08:05 AM - 08:10 AM	Q&A	Questions and Answers James F. Meschia, MD, FAAN
08:10 AM - 08:45 AM	Speaker	Therapeutic Strategies for Patients with Vascular Cognitive Impairment/Dementia Alessandro Biffi, MD
08:45 AM - 08:50 AM	Q&A	Questions and Answers Alessandro Biffi, MD
08:50 AM - 09:00 AM	Closing Remarks	Closing Remarks Mark R. Etherton, MD

Faculty Disclosures
Mark R. Etherton, MD	Dr. Etherton has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Etherton has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Argenica Therapeutics.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.

��ɫ����

��ɫ����

��ɫ��

��ɫ��